Diagnostic Value of Contrast-Enhanced Digital Mammography Versus Contrast-Enhanced MRI for Detecting Residual Disease After Neoadjuvant Chemotherapy for Breast Cancer

키워드

참고문헌 (34)

1. Lewin JM, "Dual-energy contrast-enhanced digital subtraction mammography : feasibility", Radiology, 229, pp.261~268 (2003)
2. Fallenberg EM, "Contrast-enhanced spectral mammography versus MRI : initial results in the detection of breast cancer and assessment of tumour size", Eur Radiol, 24, pp.256~264 (2014)
3. Dromain C, "Dual-energy contrast-enhanced digital mammography : initial clinical results", Eur Radiol, 21, pp.565~574 (2011)
4. Bilimoria KY, "Evaluating the impact of preoperative breast magnetic resonance imaging on the surgical management of newly diagnosed breast cancers", Arch Surg, 142, pp.441~447 (2007)
5. Lee-Felker SA, "Newly diagnosed breast cancer : comparison of contrast-enhanced spectral mammography and breast MR imaging in the evaluation of extent of disease", Radiology, 285, pp.389~400 (2017)
6. Patel BK, "Contrast-enhanced spectral mammography is comparable to MRI in the assessment of residual breast cancer following neoadjuvant systemic therapy", Ann Surg Oncol, 25, pp.1350~1356 (2018)
7. Barra FR, "Contrast-enhanced mammography(CEM)for detecting residual disease after neoadjuvant chemotherapy : a comparison with breast magnetic resonance imaging(MRI)", Biomed Res Int, 2018, pp.8531916~ (2018)
8. The Korean Society of Radiology, "Korean clinical practice guideline for adverse reactions to injectable iodinated contrast agent and gadolinium-based contrast agent injection for MRI", The Korean Society of Radiology, ~ (2016)
9. Ren B, "Dual energy iodine contrast imaging with mammography and tomosynthesis", SPIE, 8668, pp.219~227 (2013)
10. 김은영, "Diagnostic Value of Contrast-Enhanced Digital Mammography versus Contrast-Enhanced Magnetic Resonance Imaging for the Preoperative Evaluation of Breast Cancer", Journal of Breast Cancer, 21(4), pp.453~462 (2018), 한국유방암학회[DOI]
11. American College of Radiology, "ACR BI-RADS atlas: breast imaging reporting and data system", American College of Radiology, ~ (2013)
12. Eisenhauer EA, "New response evaluation criteria in solid tumours : revised RECIST guideline(version 1. 1)", Eur J Cancer, 45, pp.228~247 (2009)
13. Kim EY, "Preoperative evaluation of mammographic microcalcifications after neoadjuvant chemotherapy for breast cancer", Clin Radiol, 75, pp.641.e619~641.e627 (2020)[DOI]
14. Harvey JM, "Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer", J Clin Oncol, 17, pp.1474~1481 (1999)
15. von Minckwitz G, "Definition and impact of pathologic complete response on prognosis after neoadjuvant chemotherapy in various intrinsic breast cancer subtypes", J Clin Oncol, 30, pp.1796~1804 (2012)
16. Ogston KN, "A new histological grading system to assess response of breast cancers to primary chemotherapy : prognostic significance and survival", Breast, 12, pp.320~327 (2003)
17. Mieog JSD, "Preoperative chemotherapy for women with operable breast cancer", Cochrane Database Syst Rev, 2007, pp.CD005002~ (2007)
18. Shin HJ, "Comparison of mammography, sonography, MRI and clinical examination in patients with locally advanced or inflammatory breast cancer who underwent neoadjuvant chemotherapy", Br J Radiol, 84, pp.612~620 (2011)
19. Martincich L, "Monitoring response to primary chemotherapy in breast cancer using dynamic contrast-enhanced magnetic resonance imaging", Breast Cancer Res Treat, 83, pp.67~76 (2004)
20. Lobbes MBI, "The role of magnetic resonance imaging in assessing residual disease and pathologic complete response in breast cancer patients receiving neoadjuvant chemotherapy : a systematic review", Insights Imaging, 4, pp.163~175 (2013)
21. Hobbs MM, "Contrast-enhanced spectral mammography(CESM)and contrast enhanced MRI(CEMRI) : patient preferences and tolerance", J Med Imaging Radiat Oncol, 59, pp.300~305 (2015)
22. Youn I, "Contrast enhanced digital mammography versus magnetic resonance imaging for accurate measurement of the size of breast cancer", Br J Radiol, 92, pp.20180929~ (2019)
23. Sogani J, "Comparison of background parenchymal enhancement at contrast-enhanced spectral mammography and breast MR imaging", Radiology, 282, pp.63~73 (2017)
24. Barra FR, "Contrast-enhanced mammography(CEM)for detecting residual disease after neoadjuvant chemotherapy : a comparison with breast magnetic resonance imaging(MRI)", Biomed Res Int, 2018, pp.8531916~ (2018)
25. ElSaid NAE, "Role of contrast enhanced spectral mammography in predicting pathological response of locally advanced breast cancer post neo-adjuvant chemotherapy", Egypt J Radiol Nucl Med, 48, pp.519~527 (2017)
26. Jochelson MS, "Bilateral contrast-enhanced dual-energy digital mammography : feasibility and comparison with conventional digital mammography and MR imaging in women with known breast carcinoma", Radiology, 266, pp.743~751 (2013)
27. Iotti V, "Contrast-enhanced spectral mammography in neoadjuvant chemotherapy monitoring : a comparison with breast magnetic resonance imaging", Breast Cancer Res, 19, pp.106~ (2017)
28. Luczynska E, "Comparison between breast MRI and contrast-enhanced spectral mammography", Med Sci Monit, 21, pp.1358~1367 (2015)
29. Wu LA, "Evaluation of the treatment response to neoadjuvant chemotherapy in locally advanced breast cancer using combined magnetic resonance vascular maps and apparent diffusion coefficient", J Magn Reson Imaging, 42, pp.1407~1420 (2015)
30. Dromain C, "Dual-energy contrast-enhanced digital mammography : initial clinical results of a multireader, multicase study", Breast Cancer Res, 14, pp.R94~ (2012)
31. Kuhl CK, "MRI of breast tumors", Eur Radiol, 10, pp.46~58 (2000)
32. Hieken TJ, "Correlating sonography, mammography, and pathology in the assessment of breast cancer size", Am J Surg, 182, pp.351~354 (2001)
33. Cuesta Cuesta AB, "Accuracy of tumor size measurements performed by magnetic resonance, ultrasound and mammography, and their correlation with pathological size in primary breast cancer", Cir Esp(Engl Ed), 97, pp.391~396 (2019)
34. Gruber IV, "Measurement of tumour size with mammography, sonography and magnetic resonance imaging as compared to histological tumour size in primary breast cancer", BMC Cancer, 13, pp.328~ (2013)

관련 논문AI추천